Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
(for at least one location)
Minneapolis, MN, Rochester, MN
Describes the nature of a clinical study. Types include:
The primary objective of this study is to demonstrate that the mean change in pre-operative main thoracic Cobb angle, compared to post-oprative Cobb angle at 24 months, is signifianty greater than 0.
Study statuses change often. Please contact us for help.
Contact us for the latest status
Closed for enrollment
The primary purpose of this study is to evaluate the effectiveness of non-fusion surgical treatment of Spinal Deformity Correction in Adolescent Idiopathic Scoliosis.
The Post Approval Study (PAS) is gathering data on the Tether device and it's efficacy and safety.
Open for enrollment
Rochester, MN
This is a survey, with the option of uploading prior clinical imaging (x-rays, etc), with the aim to study the burden of scoliosis disease over time and the results of treatment (specifically the results of nonfusion and fusion scoliosis surgery). Our goal is to report these results back to the community of people with scoliosis and also publish our results in the medical literature.
Analysis of video encounters between providers, patients, and families will be used to develop a shared decision making tool for patients deciding between surgery and observation for scoliosis treatment.
The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on initial evaluation. The proposed new study aims at refining and testing the external validity of this model in a larger cohort. The next step towards using the new model in the clinical setting is to redesign the model and to externally validate the model by measuring the agreement between the new method and the traditional Cobb angle at maturity in a larger multicenter study. The ultimate goal of this research project will be to validate this new predictive model and finally transfer this new predictive tool in the hands of clinicians treating AIS.